Application of compound KYA1797K in preparation of anti-RNA (Ribonucleic Acid) virus medicine

The invention discloses an application of a compound KYA1797K in preparation of an anti-RNA (Ribonucleic Acid) virus drug, and finds an antiviral effect of the compound KYA1797K, particularly an anti-RNA virus effect, mainly that a small molecule KYA1797K can inhibit infection and replication of VSV (Virus Saturated Virus) and SARS-CoV2. The micromolecule can be used as a potential clinical test drug for treating diseases related to VSV and SARS-CoV2 infection, is expected to become a new treatment means, prolongs the lifetime of a patient, improves the life quality of the patient, and also has an important prompt effect on treatment of RNA virus related tumors. 本发明公开了化合物KYA1797K制备抗RNA病毒药物中的应用，本发明发现了化合物KYA1797K的抗病毒作用，特别是抗RNA病毒，主要是小分子KYA1797K能抑制VSV和SARS-CoV2的感染和复制。该小分子可以作为治疗VSV和SARS-CoV2感染相关疾病的潜在临床试验药物，有望成为新的治疗手段，延长患者生存期，改善患者的生存质量，对治疗RNA病毒相关的肿瘤也有重要的提示作用。